EPAD selects Aridhia data and analytics platform

On 19 January, the EPAD consortium elected to use AnalytiXagility as its data and analytics platform. AnalytiXagility belongs to Scottish clinical and translational informatics company Aridhia. The platform combines analytical, collaboration and audit tools to support and accelerate data-driven projects. It will be accessible to all of the consortium partners, and is able to carry…

Interview with Lennert Steukers

What is your current role in EPAD? I’m currently working full time as project manager for Janssen on the IMI-EPAD project. My main role, as member of the EPAD Project Management office and WP5, is to provide overall management to the project including supporting the coordinator in liaising with IMI, work plan & schedule control,…

Interview with Judi Syson

What is your current role in EPAD? I’m the International Coordinator for WP4 (EPAD cohort and proof of concept studies) based at the University of Edinburgh with Professor Craig Ritchie. I also represent WP4 on the Clinical Development Group as the Operational Manager. The roles involve working with the Trial Delivery Centres to get them…

EPAD team members meet Princess Anne in Scotland

On 15 October 2015, EPAD’s Luc Truyen, Vice-President, Neuroscience External Affairs, Janssen R&D (pictured here, with Princess Anne), along with the University of Edinburgh team, represented the EPAD consortium at a University event to launch the new offices for the Centre for Clinical Brain Sciences. They had the honour of introducing the project to Her…

EPAD ethics working group holds meeting

On 13 August 2015, EPAD’s ethics working group held an internal workshop in Amsterdam. Most of the meeting was taken up with discussions about issues to be covered in the EPAD ethical guidance document for clinicians and researchers involved in the project (in particular informed consent, disclosure of possible risk status and dealing with incidental…

EPAD AGM and consortium meeting held in Edinburgh

The European Prevention of Alzheimer’s Dementia (EPAD) project held its consortium meeting in Edinburgh, Scotland on 19 to 21 May 2015. The title of the meeting, “Science, Collaboration and Progress” was very appropriate. There were many lively debates between leading researchers, clinicians, ethicists, lawyers and representatives of both pharmaceutical companies and people with dementia (Alzheimer…

EPAD project team holds meeting on dissemination activities

The members of EPAD’s communication team held a two day meeting in Barcelona on 9-10 April 2015. They discussed the ongoing development of the project communication plan and dissemination materials, such as the website, the internal and external newsletters and the project brochure. The partners also established dissemination procedures – including impact measures – for…